# A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects

> **NCT04003402** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ASP8062
- **DRUG:** Alcohol
- **DRUG:** ASP8062 Placebo
- **DRUG:** Alcohol Placebo

## Key facts

- **NCT ID:** NCT04003402
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-16
- **Primary completion:** 2019-10-16
- **Final completion:** 2019-10-16
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04003402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04003402, "A Study to Assess Potential Interaction Between ASP8062 and Alcohol in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04003402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*